0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anterior Uveitis Treatment Market Size, Status and Forecast 2021-2027
Published Date: February 2021
|
Report Code: QYRE-Auto-11J4398
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Global Anterior Uveitis Treatment Market Size Status and Forecast 2021 2027

Global Anterior Uveitis Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-11J4398
Report
February 2021
90 Pages
QYResearch
Region: Global, North America, Europe, Canada, Germany, France, Italy, Russia, UAE, Southeast Asia, South Korea, Turkey, Saudi Arabia,
Description
Table of Content
Tables & Figures
Anterior Uveitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anterior Uveitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
    Corticosteroids
    Cycloplegic Agents
    Anti-TNF Agents
    Immunosuppressants
Segment by Application
    Hospitals
    Clinics
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Novartis AG
    Santen Pharmaceutical Co.
    AbbVie Inc.
    Eyegate Pharmaceuticals Inc.
    Clearside Biomedical Inc.
    Aldeyra Therapeutics Inc.
    Aciont Inc.
    Sirion Therapeutics Inc.
    UCB Biopharma S.P.R.L.
    Eyegate Pharmaceuticals Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anterior Uveitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Cycloplegic Agents
1.2.4 Anti-TNF Agents
1.2.5 Immunosuppressants
1.3 Market by Application
1.3.1 Global Anterior Uveitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anterior Uveitis Treatment Market Perspective (2016-2027)
2.2 Anterior Uveitis Treatment Growth Trends by Regions
2.2.1 Anterior Uveitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anterior Uveitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Anterior Uveitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Anterior Uveitis Treatment Industry Dynamic
2.3.1 Anterior Uveitis Treatment Market Trends
2.3.2 Anterior Uveitis Treatment Market Drivers
2.3.3 Anterior Uveitis Treatment Market Challenges
2.3.4 Anterior Uveitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anterior Uveitis Treatment Players by Revenue
3.1.1 Global Top Anterior Uveitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Anterior Uveitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Anterior Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anterior Uveitis Treatment Revenue
3.4 Global Anterior Uveitis Treatment Market Concentration Ratio
3.4.1 Global Anterior Uveitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anterior Uveitis Treatment Revenue in 2020
3.5 Anterior Uveitis Treatment Key Players Head office and Area Served
3.6 Key Players Anterior Uveitis Treatment Product Solution and Service
3.7 Date of Enter into Anterior Uveitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anterior Uveitis Treatment Breakdown Data by Type
4.1 Global Anterior Uveitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Anterior Uveitis Treatment Forecasted Market Size by Type (2022-2027)
5 Anterior Uveitis Treatment Breakdown Data by Application
5.1 Global Anterior Uveitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Anterior Uveitis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anterior Uveitis Treatment Market Size (2016-2027)
6.2 North America Anterior Uveitis Treatment Market Size by Type
6.2.1 North America Anterior Uveitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Anterior Uveitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Anterior Uveitis Treatment Market Size by Type (2016-2027)
6.3 North America Anterior Uveitis Treatment Market Size by Application
6.3.1 North America Anterior Uveitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Anterior Uveitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Anterior Uveitis Treatment Market Size by Application (2016-2027)
6.4 North America Anterior Uveitis Treatment Market Size by Country
6.4.1 North America Anterior Uveitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Anterior Uveitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anterior Uveitis Treatment Market Size (2016-2027)
7.2 Europe Anterior Uveitis Treatment Market Size by Type
7.2.1 Europe Anterior Uveitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Anterior Uveitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Anterior Uveitis Treatment Market Size by Type (2016-2027)
7.3 Europe Anterior Uveitis Treatment Market Size by Application
7.3.1 Europe Anterior Uveitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Anterior Uveitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Anterior Uveitis Treatment Market Size by Application (2016-2027)
7.4 Europe Anterior Uveitis Treatment Market Size by Country
7.4.1 Europe Anterior Uveitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Anterior Uveitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anterior Uveitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Type
8.2.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Application
8.3.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Anterior Uveitis Treatment Market Size by Region
8.4.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anterior Uveitis Treatment Market Size (2016-2027)
9.2 Latin America Anterior Uveitis Treatment Market Size by Type
9.2.1 Latin America Anterior Uveitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Anterior Uveitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Anterior Uveitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Anterior Uveitis Treatment Market Size by Application
9.3.1 Latin America Anterior Uveitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Anterior Uveitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Anterior Uveitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Anterior Uveitis Treatment Market Size by Country
9.4.1 Latin America Anterior Uveitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Anterior Uveitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anterior Uveitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Type
10.2.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Application
10.3.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Anterior Uveitis Treatment Market Size by Country
10.4.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Anterior Uveitis Treatment Introduction
11.1.4 Novartis AG Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Santen Pharmaceutical Co.
11.2.1 Santen Pharmaceutical Co. Company Details
11.2.2 Santen Pharmaceutical Co. Business Overview
11.2.3 Santen Pharmaceutical Co. Anterior Uveitis Treatment Introduction
11.2.4 Santen Pharmaceutical Co. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.2.5 Santen Pharmaceutical Co. Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Anterior Uveitis Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.3.5 AbbVie Inc. Recent Development
11.4 Eyegate Pharmaceuticals Inc.
11.4.1 Eyegate Pharmaceuticals Inc. Company Details
11.4.2 Eyegate Pharmaceuticals Inc. Business Overview
11.4.3 Eyegate Pharmaceuticals Inc. Anterior Uveitis Treatment Introduction
11.4.4 Eyegate Pharmaceuticals Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.4.5 Eyegate Pharmaceuticals Inc. Recent Development
11.5 Clearside Biomedical Inc.
11.5.1 Clearside Biomedical Inc. Company Details
11.5.2 Clearside Biomedical Inc. Business Overview
11.5.3 Clearside Biomedical Inc. Anterior Uveitis Treatment Introduction
11.5.4 Clearside Biomedical Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.5.5 Clearside Biomedical Inc. Recent Development
11.6 Aldeyra Therapeutics Inc.
11.6.1 Aldeyra Therapeutics Inc. Company Details
11.6.2 Aldeyra Therapeutics Inc. Business Overview
11.6.3 Aldeyra Therapeutics Inc. Anterior Uveitis Treatment Introduction
11.6.4 Aldeyra Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.6.5 Aldeyra Therapeutics Inc. Recent Development
11.7 Aciont Inc.
11.7.1 Aciont Inc. Company Details
11.7.2 Aciont Inc. Business Overview
11.7.3 Aciont Inc. Anterior Uveitis Treatment Introduction
11.7.4 Aciont Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.7.5 Aciont Inc. Recent Development
11.8 Sirion Therapeutics Inc.
11.8.1 Sirion Therapeutics Inc. Company Details
11.8.2 Sirion Therapeutics Inc. Business Overview
11.8.3 Sirion Therapeutics Inc. Anterior Uveitis Treatment Introduction
11.8.4 Sirion Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.8.5 Sirion Therapeutics Inc. Recent Development
11.9 UCB Biopharma S.P.R.L.
11.9.1 UCB Biopharma S.P.R.L. Company Details
11.9.2 UCB Biopharma S.P.R.L. Business Overview
11.9.3 UCB Biopharma S.P.R.L. Anterior Uveitis Treatment Introduction
11.9.4 UCB Biopharma S.P.R.L. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.9.5 UCB Biopharma S.P.R.L. Recent Development
11.10 Lux Biosciences Inc.
11.10.1 Lux Biosciences Inc. Company Details
11.10.2 Lux Biosciences Inc. Business Overview
11.10.3 Lux Biosciences Inc. Anterior Uveitis Treatment Introduction
11.10.4 Lux Biosciences Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.10.5 Lux Biosciences Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Anterior Uveitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Corticosteroids
    Table 3. Key Players of Cycloplegic Agents
    Table 4. Key Players of Anti-TNF Agents
    Table 5. Key Players of Immunosuppressants
    Table 6. Global Anterior Uveitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Anterior Uveitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Anterior Uveitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Anterior Uveitis Treatment Market Share by Regions (2016-2021)
    Table 10. Global Anterior Uveitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Anterior Uveitis Treatment Market Share by Regions (2022-2027)
    Table 12. Anterior Uveitis Treatment Market Trends
    Table 13. Anterior Uveitis Treatment Market Drivers
    Table 14. Anterior Uveitis Treatment Market Challenges
    Table 15. Anterior Uveitis Treatment Market Restraints
    Table 16. Global Anterior Uveitis Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Anterior Uveitis Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Anterior Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anterior Uveitis Treatment as of 2020)
    Table 19. Ranking of Global Top Anterior Uveitis Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Anterior Uveitis Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Anterior Uveitis Treatment Product Solution and Service
    Table 23. Date of Enter into Anterior Uveitis Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Anterior Uveitis Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Anterior Uveitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Anterior Uveitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Anterior Uveitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Anterior Uveitis Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Anterior Uveitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Anterior Uveitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 63. Novartis AG Company Details
    Table 64. Novartis AG Business Overview
    Table 65. Novartis AG Anterior Uveitis Treatment Product
    Table 66. Novartis AG Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 67. Novartis AG Recent Development
    Table 68. Santen Pharmaceutical Co. Company Details
    Table 69. Santen Pharmaceutical Co. Business Overview
    Table 70. Santen Pharmaceutical Co. Anterior Uveitis Treatment Product
    Table 71. Santen Pharmaceutical Co. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 72. Santen Pharmaceutical Co. Recent Development
    Table 73. AbbVie Inc. Company Details
    Table 74. AbbVie Inc. Business Overview
    Table 75. AbbVie Inc. Anterior Uveitis Treatment Product
    Table 76. AbbVie Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 77. AbbVie Inc. Recent Development
    Table 78. Eyegate Pharmaceuticals Inc. Company Details
    Table 79. Eyegate Pharmaceuticals Inc. Business Overview
    Table 80. Eyegate Pharmaceuticals Inc. Anterior Uveitis Treatment Product
    Table 81. Eyegate Pharmaceuticals Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 82. Eyegate Pharmaceuticals Inc. Recent Development
    Table 83. Clearside Biomedical Inc. Company Details
    Table 84. Clearside Biomedical Inc. Business Overview
    Table 85. Clearside Biomedical Inc. Anterior Uveitis Treatment Product
    Table 86. Clearside Biomedical Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 87. Clearside Biomedical Inc. Recent Development
    Table 88. Aldeyra Therapeutics Inc. Company Details
    Table 89. Aldeyra Therapeutics Inc. Business Overview
    Table 90. Aldeyra Therapeutics Inc. Anterior Uveitis Treatment Product
    Table 91. Aldeyra Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 92. Aldeyra Therapeutics Inc. Recent Development
    Table 93. Aciont Inc. Company Details
    Table 94. Aciont Inc. Business Overview
    Table 95. Aciont Inc. Anterior Uveitis Treatment Product
    Table 96. Aciont Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 97. Aciont Inc. Recent Development
    Table 98. Sirion Therapeutics Inc. Company Details
    Table 99. Sirion Therapeutics Inc. Business Overview
    Table 100. Sirion Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 101. Sirion Therapeutics Inc. Recent Development
    Table 102. UCB Biopharma S.P.R.L. Company Details
    Table 103. UCB Biopharma S.P.R.L. Business Overview
    Table 104. UCB Biopharma S.P.R.L. Anterior Uveitis Treatment Product
    Table 105. UCB Biopharma S.P.R.L. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 106. UCB Biopharma S.P.R.L. Recent Development
    Table 107. Lux Biosciences Inc. Company Details
    Table 108. Lux Biosciences Inc. Business Overview
    Table 109. Lux Biosciences Inc. Anterior Uveitis Treatment Product
    Table 110. Lux Biosciences Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 111. Lux Biosciences Inc. Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anterior Uveitis Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Corticosteroids Features
    Figure 3. Cycloplegic Agents Features
    Figure 4. Anti-TNF Agents Features
    Figure 5. Immunosuppressants Features
    Figure 6. Global Anterior Uveitis Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Anterior Uveitis Treatment Report Years Considered
    Figure 11. Global Anterior Uveitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Anterior Uveitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Anterior Uveitis Treatment Market Share by Regions: 2020 VS 2027
    Figure 14. Global Anterior Uveitis Treatment Market Share by Regions (2022-2027)
    Figure 15. Global Anterior Uveitis Treatment Market Share by Players in 2020
    Figure 16. Global Top Anterior Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anterior Uveitis Treatment as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Anterior Uveitis Treatment Revenue in 2020
    Figure 18. Global Anterior Uveitis Treatment Revenue Market Share by Type (2016-2021)
    Figure 19. Global Anterior Uveitis Treatment Revenue Market Share by Type (2022-2027)
    Figure 20. North America Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 22. North America Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 23. North America Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 24. United States Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 28. Europe Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 29. Europe Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 30. Germany Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Anterior Uveitis Treatment Market Share by Region (2016-2027)
    Figure 40. China Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 48. Latin America Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 49. Latin America Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 50. Mexico Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 56. Turkey Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Novartis AG Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 60. Santen Pharmaceutical Co. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 61. AbbVie Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 62. Eyegate Pharmaceuticals Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 63. Clearside Biomedical Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 64. Aldeyra Therapeutics Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 65. Aciont Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 66. Sirion Therapeutics Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 67. UCB Biopharma S.P.R.L. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 68. Lux Biosciences Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Anterior Uveitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anterior Uveitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
    Corticosteroids
    Cycloplegic Agents
    Anti-TNF Agents
    Immunosuppressants
Segment by Application
    Hospitals
    Clinics
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Novartis AG
    Santen Pharmaceutical Co.
    AbbVie Inc.
    Eyegate Pharmaceuticals Inc.
    Clearside Biomedical Inc.
    Aldeyra Therapeutics Inc.
    Aciont Inc.
    Sirion Therapeutics Inc.
    UCB Biopharma S.P.R.L.
    Eyegate Pharmaceuticals Inc.
Read More
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anterior Uveitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Cycloplegic Agents
1.2.4 Anti-TNF Agents
1.2.5 Immunosuppressants
1.3 Market by Application
1.3.1 Global Anterior Uveitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anterior Uveitis Treatment Market Perspective (2016-2027)
2.2 Anterior Uveitis Treatment Growth Trends by Regions
2.2.1 Anterior Uveitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anterior Uveitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Anterior Uveitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Anterior Uveitis Treatment Industry Dynamic
2.3.1 Anterior Uveitis Treatment Market Trends
2.3.2 Anterior Uveitis Treatment Market Drivers
2.3.3 Anterior Uveitis Treatment Market Challenges
2.3.4 Anterior Uveitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anterior Uveitis Treatment Players by Revenue
3.1.1 Global Top Anterior Uveitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Anterior Uveitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Anterior Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anterior Uveitis Treatment Revenue
3.4 Global Anterior Uveitis Treatment Market Concentration Ratio
3.4.1 Global Anterior Uveitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anterior Uveitis Treatment Revenue in 2020
3.5 Anterior Uveitis Treatment Key Players Head office and Area Served
3.6 Key Players Anterior Uveitis Treatment Product Solution and Service
3.7 Date of Enter into Anterior Uveitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anterior Uveitis Treatment Breakdown Data by Type
4.1 Global Anterior Uveitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Anterior Uveitis Treatment Forecasted Market Size by Type (2022-2027)
5 Anterior Uveitis Treatment Breakdown Data by Application
5.1 Global Anterior Uveitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Anterior Uveitis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anterior Uveitis Treatment Market Size (2016-2027)
6.2 North America Anterior Uveitis Treatment Market Size by Type
6.2.1 North America Anterior Uveitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Anterior Uveitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Anterior Uveitis Treatment Market Size by Type (2016-2027)
6.3 North America Anterior Uveitis Treatment Market Size by Application
6.3.1 North America Anterior Uveitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Anterior Uveitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Anterior Uveitis Treatment Market Size by Application (2016-2027)
6.4 North America Anterior Uveitis Treatment Market Size by Country
6.4.1 North America Anterior Uveitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Anterior Uveitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anterior Uveitis Treatment Market Size (2016-2027)
7.2 Europe Anterior Uveitis Treatment Market Size by Type
7.2.1 Europe Anterior Uveitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Anterior Uveitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Anterior Uveitis Treatment Market Size by Type (2016-2027)
7.3 Europe Anterior Uveitis Treatment Market Size by Application
7.3.1 Europe Anterior Uveitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Anterior Uveitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Anterior Uveitis Treatment Market Size by Application (2016-2027)
7.4 Europe Anterior Uveitis Treatment Market Size by Country
7.4.1 Europe Anterior Uveitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Anterior Uveitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anterior Uveitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Type
8.2.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Application
8.3.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Anterior Uveitis Treatment Market Size by Region
8.4.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anterior Uveitis Treatment Market Size (2016-2027)
9.2 Latin America Anterior Uveitis Treatment Market Size by Type
9.2.1 Latin America Anterior Uveitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Anterior Uveitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Anterior Uveitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Anterior Uveitis Treatment Market Size by Application
9.3.1 Latin America Anterior Uveitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Anterior Uveitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Anterior Uveitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Anterior Uveitis Treatment Market Size by Country
9.4.1 Latin America Anterior Uveitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Anterior Uveitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anterior Uveitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Type
10.2.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Application
10.3.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Anterior Uveitis Treatment Market Size by Country
10.4.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Anterior Uveitis Treatment Introduction
11.1.4 Novartis AG Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Santen Pharmaceutical Co.
11.2.1 Santen Pharmaceutical Co. Company Details
11.2.2 Santen Pharmaceutical Co. Business Overview
11.2.3 Santen Pharmaceutical Co. Anterior Uveitis Treatment Introduction
11.2.4 Santen Pharmaceutical Co. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.2.5 Santen Pharmaceutical Co. Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Anterior Uveitis Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.3.5 AbbVie Inc. Recent Development
11.4 Eyegate Pharmaceuticals Inc.
11.4.1 Eyegate Pharmaceuticals Inc. Company Details
11.4.2 Eyegate Pharmaceuticals Inc. Business Overview
11.4.3 Eyegate Pharmaceuticals Inc. Anterior Uveitis Treatment Introduction
11.4.4 Eyegate Pharmaceuticals Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.4.5 Eyegate Pharmaceuticals Inc. Recent Development
11.5 Clearside Biomedical Inc.
11.5.1 Clearside Biomedical Inc. Company Details
11.5.2 Clearside Biomedical Inc. Business Overview
11.5.3 Clearside Biomedical Inc. Anterior Uveitis Treatment Introduction
11.5.4 Clearside Biomedical Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.5.5 Clearside Biomedical Inc. Recent Development
11.6 Aldeyra Therapeutics Inc.
11.6.1 Aldeyra Therapeutics Inc. Company Details
11.6.2 Aldeyra Therapeutics Inc. Business Overview
11.6.3 Aldeyra Therapeutics Inc. Anterior Uveitis Treatment Introduction
11.6.4 Aldeyra Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.6.5 Aldeyra Therapeutics Inc. Recent Development
11.7 Aciont Inc.
11.7.1 Aciont Inc. Company Details
11.7.2 Aciont Inc. Business Overview
11.7.3 Aciont Inc. Anterior Uveitis Treatment Introduction
11.7.4 Aciont Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.7.5 Aciont Inc. Recent Development
11.8 Sirion Therapeutics Inc.
11.8.1 Sirion Therapeutics Inc. Company Details
11.8.2 Sirion Therapeutics Inc. Business Overview
11.8.3 Sirion Therapeutics Inc. Anterior Uveitis Treatment Introduction
11.8.4 Sirion Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.8.5 Sirion Therapeutics Inc. Recent Development
11.9 UCB Biopharma S.P.R.L.
11.9.1 UCB Biopharma S.P.R.L. Company Details
11.9.2 UCB Biopharma S.P.R.L. Business Overview
11.9.3 UCB Biopharma S.P.R.L. Anterior Uveitis Treatment Introduction
11.9.4 UCB Biopharma S.P.R.L. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.9.5 UCB Biopharma S.P.R.L. Recent Development
11.10 Lux Biosciences Inc.
11.10.1 Lux Biosciences Inc. Company Details
11.10.2 Lux Biosciences Inc. Business Overview
11.10.3 Lux Biosciences Inc. Anterior Uveitis Treatment Introduction
11.10.4 Lux Biosciences Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.10.5 Lux Biosciences Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Read More
List of Tables
    Table 1. Global Anterior Uveitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Corticosteroids
    Table 3. Key Players of Cycloplegic Agents
    Table 4. Key Players of Anti-TNF Agents
    Table 5. Key Players of Immunosuppressants
    Table 6. Global Anterior Uveitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Anterior Uveitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Anterior Uveitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Anterior Uveitis Treatment Market Share by Regions (2016-2021)
    Table 10. Global Anterior Uveitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Anterior Uveitis Treatment Market Share by Regions (2022-2027)
    Table 12. Anterior Uveitis Treatment Market Trends
    Table 13. Anterior Uveitis Treatment Market Drivers
    Table 14. Anterior Uveitis Treatment Market Challenges
    Table 15. Anterior Uveitis Treatment Market Restraints
    Table 16. Global Anterior Uveitis Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Anterior Uveitis Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Anterior Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anterior Uveitis Treatment as of 2020)
    Table 19. Ranking of Global Top Anterior Uveitis Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Anterior Uveitis Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Anterior Uveitis Treatment Product Solution and Service
    Table 23. Date of Enter into Anterior Uveitis Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Anterior Uveitis Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Anterior Uveitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Anterior Uveitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Anterior Uveitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Anterior Uveitis Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Anterior Uveitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Anterior Uveitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 63. Novartis AG Company Details
    Table 64. Novartis AG Business Overview
    Table 65. Novartis AG Anterior Uveitis Treatment Product
    Table 66. Novartis AG Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 67. Novartis AG Recent Development
    Table 68. Santen Pharmaceutical Co. Company Details
    Table 69. Santen Pharmaceutical Co. Business Overview
    Table 70. Santen Pharmaceutical Co. Anterior Uveitis Treatment Product
    Table 71. Santen Pharmaceutical Co. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 72. Santen Pharmaceutical Co. Recent Development
    Table 73. AbbVie Inc. Company Details
    Table 74. AbbVie Inc. Business Overview
    Table 75. AbbVie Inc. Anterior Uveitis Treatment Product
    Table 76. AbbVie Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 77. AbbVie Inc. Recent Development
    Table 78. Eyegate Pharmaceuticals Inc. Company Details
    Table 79. Eyegate Pharmaceuticals Inc. Business Overview
    Table 80. Eyegate Pharmaceuticals Inc. Anterior Uveitis Treatment Product
    Table 81. Eyegate Pharmaceuticals Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 82. Eyegate Pharmaceuticals Inc. Recent Development
    Table 83. Clearside Biomedical Inc. Company Details
    Table 84. Clearside Biomedical Inc. Business Overview
    Table 85. Clearside Biomedical Inc. Anterior Uveitis Treatment Product
    Table 86. Clearside Biomedical Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 87. Clearside Biomedical Inc. Recent Development
    Table 88. Aldeyra Therapeutics Inc. Company Details
    Table 89. Aldeyra Therapeutics Inc. Business Overview
    Table 90. Aldeyra Therapeutics Inc. Anterior Uveitis Treatment Product
    Table 91. Aldeyra Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 92. Aldeyra Therapeutics Inc. Recent Development
    Table 93. Aciont Inc. Company Details
    Table 94. Aciont Inc. Business Overview
    Table 95. Aciont Inc. Anterior Uveitis Treatment Product
    Table 96. Aciont Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 97. Aciont Inc. Recent Development
    Table 98. Sirion Therapeutics Inc. Company Details
    Table 99. Sirion Therapeutics Inc. Business Overview
    Table 100. Sirion Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 101. Sirion Therapeutics Inc. Recent Development
    Table 102. UCB Biopharma S.P.R.L. Company Details
    Table 103. UCB Biopharma S.P.R.L. Business Overview
    Table 104. UCB Biopharma S.P.R.L. Anterior Uveitis Treatment Product
    Table 105. UCB Biopharma S.P.R.L. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 106. UCB Biopharma S.P.R.L. Recent Development
    Table 107. Lux Biosciences Inc. Company Details
    Table 108. Lux Biosciences Inc. Business Overview
    Table 109. Lux Biosciences Inc. Anterior Uveitis Treatment Product
    Table 110. Lux Biosciences Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
    Table 111. Lux Biosciences Inc. Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anterior Uveitis Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Corticosteroids Features
    Figure 3. Cycloplegic Agents Features
    Figure 4. Anti-TNF Agents Features
    Figure 5. Immunosuppressants Features
    Figure 6. Global Anterior Uveitis Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Anterior Uveitis Treatment Report Years Considered
    Figure 11. Global Anterior Uveitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Anterior Uveitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Anterior Uveitis Treatment Market Share by Regions: 2020 VS 2027
    Figure 14. Global Anterior Uveitis Treatment Market Share by Regions (2022-2027)
    Figure 15. Global Anterior Uveitis Treatment Market Share by Players in 2020
    Figure 16. Global Top Anterior Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anterior Uveitis Treatment as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Anterior Uveitis Treatment Revenue in 2020
    Figure 18. Global Anterior Uveitis Treatment Revenue Market Share by Type (2016-2021)
    Figure 19. Global Anterior Uveitis Treatment Revenue Market Share by Type (2022-2027)
    Figure 20. North America Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 22. North America Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 23. North America Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 24. United States Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 28. Europe Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 29. Europe Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 30. Germany Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Anterior Uveitis Treatment Market Share by Region (2016-2027)
    Figure 40. China Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 48. Latin America Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 49. Latin America Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 50. Mexico Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Anterior Uveitis Treatment Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Anterior Uveitis Treatment Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Anterior Uveitis Treatment Market Share by Country (2016-2027)
    Figure 56. Turkey Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Novartis AG Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 60. Santen Pharmaceutical Co. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 61. AbbVie Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 62. Eyegate Pharmaceuticals Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 63. Clearside Biomedical Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 64. Aldeyra Therapeutics Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 65. Aciont Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 66. Sirion Therapeutics Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 67. UCB Biopharma S.P.R.L. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 68. Lux Biosciences Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

0 Items
X
No items in the cart.
$0.0